Benjamin Edwards Inc. Raises Stock Holdings in U.S. Physical Therapy, Inc. (NYSE:USPH)

Benjamin Edwards Inc. grew its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 117.6% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,885 shares of the company’s stock after buying an additional 3,181 shares during the period. Benjamin Edwards Inc.’s holdings in U.S. Physical Therapy were worth $498,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of USPH. Dimensional Fund Advisors LP lifted its position in U.S. Physical Therapy by 2.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 423,846 shares of the company’s stock valued at $39,173,000 after acquiring an additional 10,462 shares during the period. Envestnet Asset Management Inc. lifted its holdings in shares of U.S. Physical Therapy by 4.1% during the second quarter. Envestnet Asset Management Inc. now owns 239,982 shares of the company’s stock valued at $22,179,000 after purchasing an additional 9,434 shares during the last quarter. Rockefeller Capital Management L.P. boosted its position in shares of U.S. Physical Therapy by 18.8% in the 3rd quarter. Rockefeller Capital Management L.P. now owns 160,441 shares of the company’s stock worth $13,578,000 after purchasing an additional 25,393 shares in the last quarter. Bank of New York Mellon Corp grew its stake in shares of U.S. Physical Therapy by 3.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 157,052 shares of the company’s stock worth $14,515,000 after buying an additional 5,111 shares during the last quarter. Finally, Bahl & Gaynor Inc. increased its position in U.S. Physical Therapy by 1.5% during the 2nd quarter. Bahl & Gaynor Inc. now owns 106,476 shares of the company’s stock valued at $9,841,000 after buying an additional 1,623 shares in the last quarter.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on USPH shares. Barrington Research reissued an “outperform” rating and issued a $108.00 target price on shares of U.S. Physical Therapy in a research note on Thursday, November 21st. JPMorgan Chase & Co. increased their price objective on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a research report on Tuesday, December 3rd. Bank of America restated a “neutral” rating and set a $90.00 price objective (down from $114.00) on shares of U.S. Physical Therapy in a research note on Monday, October 7th. Finally, StockNews.com upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st.

U.S. Physical Therapy Trading Down 1.6 %

U.S. Physical Therapy stock opened at $96.08 on Monday. U.S. Physical Therapy, Inc. has a one year low of $76.18 and a one year high of $113.63. The business’s fifty day moving average is $88.04 and its 200 day moving average is $90.09. The stock has a market capitalization of $1.45 billion, a PE ratio of 102.21, a price-to-earnings-growth ratio of 4.34 and a beta of 1.46. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78.

U.S. Physical Therapy Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Friday, November 15th were paid a $0.44 dividend. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.83%. U.S. Physical Therapy’s dividend payout ratio is presently 187.23%.

Insider Activity

In other news, insider Eric Joseph Williams sold 2,000 shares of the business’s stock in a transaction on Friday, November 8th. The shares were sold at an average price of $95.84, for a total transaction of $191,680.00. Following the completion of the sale, the insider now owns 14,814 shares of the company’s stock, valued at $1,419,773.76. The trade was a 11.89 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Nancy Ham sold 1,172 shares of the company’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $96.72, for a total value of $113,355.84. Following the completion of the sale, the director now owns 1,112 shares of the company’s stock, valued at $107,552.64. This trade represents a 51.31 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 6,896 shares of company stock valued at $656,940 over the last three months. Insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.